These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
454 related items for PubMed ID: 17609405
1. Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism. Vezzosi D, Bennet A, Fauvel J, Caron P. Eur J Endocrinol; 2007 Jul; 157(1):75-83. PubMed ID: 17609405 [Abstract] [Full Text] [Related]
2. Insulin levels measured with an insulin-specific assay in patients with fasting hypoglycaemia related to endogenous hyperinsulinism. Vezzosi D, Bennet A, Fauvel J, Boulanger C, Tazi O, Louvet JP, Caron P. Eur J Endocrinol; 2003 Nov; 149(5):413-9. PubMed ID: 14585087 [Abstract] [Full Text] [Related]
3. Increased plasma β-hydroxybutyrate levels during the fasting test in patients with endogenous hyperinsulinaemic hypoglycaemia. Buffet A, Vezzosi D, Maiza JC, Grunenwald S, Bennet A, Caron P. Eur J Endocrinol; 2013 Jul; 169(1):91-7. PubMed ID: 23657581 [Abstract] [Full Text] [Related]
4. Assessment of hyperinsulinaemia at the termination of the prolonged fast. Wiesli P, Brändle M, Zapf J, Seiler H, Zwimpfer C, Spinas GA, Schmid C. Clin Chim Acta; 2004 Apr; 342(1-2):227-31. PubMed ID: 15026285 [Abstract] [Full Text] [Related]
5. C-peptide level concomitant with hypoglycemia gives better performances than insulin for the diagnosis of endogenous hyperinsulinism: a single-center study of 159 fasting trials. Bonnet-Serrano F, Devin-Genteuil C, Thomeret L, Laguillier-Morizot C, Leguy MC, Vaczlavik A, Bouys L, Zientek C, Bricaire L, Bessiène L, Guignat L, Libé R, Mosnier-Pudar H, Assié G, Groussin L, Guibourdenche J, Bertherat J. Eur J Endocrinol; 2023 Feb 14; 188(2):. PubMed ID: 36756737 [Abstract] [Full Text] [Related]
6. A glucose reduction challenge in the differential diagnosis of fasting hypoglycemia: a two-center study. Ipp E, Sinai Y, Forster B, Cortez C, Baroz B, Nesher R, Cerasi E. J Clin Endocrinol Metab; 1990 Mar 14; 70(3):711-7. PubMed ID: 2407752 [Abstract] [Full Text] [Related]
7. Mini-fasting tests diagnosing endogenous hyperinsulinism: a follow-up of 26 cases. Felício JS, Koury CC, Martins CL, Miléo KB, Neto JF, de Melo FT, de Souza AC. Exp Clin Endocrinol Diabetes; 2014 Mar 14; 122(3):149-53. PubMed ID: 24643691 [Abstract] [Full Text] [Related]
8. [Diagnosis of insulinomas. Determination of insulin, C-peptide and proinsulin in blood to differentiate between endogenous and exogenous hyperinsulinism]. Hanssen KF, Torjesen PA, Heding LG. Tidsskr Nor Laegeforen; 1981 Dec 10; 101(34-36):1957-60. PubMed ID: 6280336 [No Abstract] [Full Text] [Related]
9. Normal proinsulin processing despite beta-cell dysfunction in persistent hyperinsulinaemic hypoglycaemia of infancy (nesidioblastosis). Leibowitz G, Weintrob N, Pikarsky A, Josefsberg Z, Landau H, Glaser B, Hales CN, Cerasi E. Diabetologia; 1996 Nov 10; 39(11):1338-44. PubMed ID: 8933002 [Abstract] [Full Text] [Related]
10. A soluble-phase proinsulin radioimmunoassay and its use in diagnosis of hypoglycaemia. Naylor BA, Matthews DR, Turner RC. Ann Clin Biochem; 1987 Jul 10; 24 ( Pt 4)():352-63. PubMed ID: 3310832 [Abstract] [Full Text] [Related]
11. Modified hyperinsulinaemic, eu- and hypoglycaemic clamp technique using lispro-insulin for insulinoma diagnostic. Roudovitch N, Nauck MA, Schatz H, Pfeiffer AF. Exp Clin Endocrinol Diabetes; 2001 Jul 10; 109(8):397-401. PubMed ID: 11748487 [Abstract] [Full Text] [Related]
12. The diagnosis of fasting hypoglycemia due to an islet-cell tumor obscured by a highly specific insulin assay. Chia CW, Saudek CD. J Clin Endocrinol Metab; 2003 Apr 10; 88(4):1464-7. PubMed ID: 12679423 [Abstract] [Full Text] [Related]
13. A direct assay for proinsulin in plasma and its applications in hypoglycaemia. Hampton SM, Beyzavi K, Teale D, Marks V. Clin Endocrinol (Oxf); 1988 Jul 10; 29(1):9-16. PubMed ID: 3073882 [Abstract] [Full Text] [Related]
15. A plasma glucose concentration below 2.5 mmol L-1 is not an appropriate criterion to end the 72-h fast. Wiesli P, Brändle M, Schwegler B, Lehmann R, Spinas GA, Schmid C. J Intern Med; 2002 Dec 10; 252(6):504-9. PubMed ID: 12472910 [Abstract] [Full Text] [Related]